Atlas Trials

A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis

Clinical trial NCT07173478 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07173478
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis (AD)
Start date
2025-10-01
Primary completion
2026-12-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.